Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
23.00
-0.23 (-0.99%)
At close: Oct 6, 2025, 4:00 PM EDT
23.00
0.00 (0.00%)
After-hours: Oct 6, 2025, 4:42 PM EDT
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $3.08 billion as of October 6, 2025. Its market cap has increased by 52.67% in one year.
Market Cap
3.08B
Enterprise Value
2.95B
1-Year Change
52.67%
Ranking
Category
Stock Price
$23.00
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $3.08B, an increase of 76.36%. That is a compound annual growth rate of 13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 3.11B | 41.03% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.16B |
| Johnson & Johnson | 453.95B |
| AbbVie | 408.13B |
| UnitedHealth Group | 326.48B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |